Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA?
- 22 June 2004
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 62 (12) , 2313-2315
- https://doi.org/10.1212/01.wnl.0000130500.44011.75
Abstract
The authors examined the relationships between sex and race and antithrombotics prescribed at discharge in the Michigan Medicare population using retrospective medical record abstraction (n = 2,715) for the period January 1, 2001, to June 30, 2001. There were no differences in the use of antithrombotics at discharge by race or sex and no differences in the prescribing of aspirin, warfarin, aspirin/extended release dipyridamole, or clopidogrel by race or sex after adjustment for confounders.Keywords
This publication has 9 references indexed in Scilit:
- Change in the Quality of Care Delivered to Medicare Beneficiaries, 1998-1999 to 2000-2001JAMA, 2003
- Sex Differences and Similarities in the Management and Outcome of Stroke PatientsStroke, 2000
- Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial FibrillationStroke, 2000
- Use of Nursing Home After Stroke and Dependence on Stroke SeverityStroke, 1999
- Accuracy of ICD-9-CM Coding for the Identification of Patients With Acute Ischemic StrokeStroke, 1998
- Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic StrokeCirculation, 1996
- Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarctionNeurology, 1995
- Racial Variations in the Rates of Carotid Angiography and Endarterectomy in Patients With Stroke and Transient Ischemic AttackArchives of internal medicine (1960), 1993